申请人:Smithkline Beckman Corporation
公开号:US04514394A1
公开(公告)日:1985-04-30
6-Chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines whose structures have an isopropylsulfonyl, isopropylthio, isobutylsulfonyl or isobutylthio group substituted at the 4-position of the 1-phenyl substituent have potent renal dopaminergic and anti-hypertensive activity.
在1-苯基取代基的4-位置上,结构带有异丙基磺酰基、异丙硫基、异丁基磺酰基或异丁硫基的6-氯-7,8-二羟基-1-苯基-2,3,4,5-四氢-1H-3-苯并哌啶具有强效肾多巴胺能和抗高血压活性。